Shanghai Smi Lt (600649.SS) traded flat 0 % during a 24 hours period ending at 07:10 PM Central Europe on Monday 26th. One Shanghai Smi Lt stock can currently be bought for about CNY 3.73 on popular exchanges. Current supply of Shanghai Smi Lt stocks is 2.5 bn. Shanghai Smi Lt has a current market capitalization of CNY 9.1 bn and approximately CNY 72.6 mn worth of Shanghai Smi Lt was traded on exchanges in the last 24 hours. Since last month end, Shanghai Smi Lt has traded -8.75 % down. Simple moving average of last 200 days is at CNY 3.76. The highest price of past 52 weeks was recorded at CNY 5.78 on 02/05/2026. 52 weeks low was at CNY 3.37 on 06/29/2026.

Here is how related stocks have performed in the past 24 hours:

  • Shanghai Shyndec Pharmaceu (600420.SS) traded flat 0 % and now trades at CNY 8.23. Current market capitalisation for Shanghai Shyndec Pharmaceu is CNY 10.9 bn. Shanghai Shyndec Pharmaceu has a current price to earnings ratio of 19.85.

  • Focus (002315.SZ) traded flat 0 % and now trades at CNY 28.18. Focus has a market capitalisation of CNY 10.9 bn. Focus has a current price to earnings ratio of 23.59.

  • Shenzhen Heungkong (600162.SS) traded flat 0 % and now trades at CNY 3.3. Shenzhen Heungkong has a market capitalisation of CNY 10.9 bn.

  • Estun Automation (2715.HK) traded up 12.99 % and now trades at HKD 13.46. Estun Automation has a market capitalisation of HKD 12.8 bn. Estun Automation has a current price to earnings ratio of 242.99. In recent trading, Hong Kong’s major indices moved lower, with the Hang Seng dropping more than four percent over the week. Market activity was influenced by a mix of sector‑specific developments: the semiconductor chain experienced a sharp fall and a subsequent rebound, while artificial‑intelligence hardware and related stocks saw mixed performance. Investor sentiment appeared to shift in response to corporate announcements, notably a strategic collaboration between Hansoh Bio and Roche that generated significant attention. New‑issue shares faced selling pressure, yet some technology‑focused stocks rallied later in the week. Across the market, exchange‑traded funds largely reflected the semiconductor and pharmaceutical themes, with robotics and automotive sectors showing relative strength as commodity and energy prices fluctuated. Net capital flows from Mainland investors were negative, with a notable outflow in the fourth trading day, indicating a cautious stance from cross‑border investors during the period.

  • Chengdu Olymvax Biopharmac (688319.SS) traded flat 0 % and now trades at CNY 26.3. Current market capitalisation for Chengdu Olymvax Biopharmac is CNY 10.9 bn.

About Shanghai Smi Lt

Shanghai SMI Holding Co.,Ltd is a real estate development company based in China’s Shanghai city. The company specializes in the development of residential areas, affordable housing, office buildings, and industrial park projects. Additionally, Shanghai SMI Holding Co.,Ltd also conducts equity investment businesses. You can find more information about their activities and initiatives on their website at www.smi-co.com or through trading on the Shanghai Stock Exchange. The initial public offering (IPO) of the company took place on October 29, 1992.